We have previously shown that non-HDL-apoC-III is proportionate to the number of metabolic syndrome criteria [3] supporting contribution to cardiovascular risk in obesity, a proposed contributor to the syndrome [4]. This evidence concerns the gene APOC3 and obesity disorder.